Likewise, the inactivation of focal adhesion kinase (FAK) and CDK4/6 induced by a combination of a FAK inhibitor, PND1186, and palbociclib also showed greater antiproliferative effects on CCA in vitro and in vivo [100]. Here, CDK4 is linked to cholangiocarcinoma.